Insights into human antifungal immunity from primary immunodeficiencies
The Lancet Infectious Diseases, ISSN: 1473-3099, Vol: 11, Issue: 10, Page: 780-792
2011
- 63Citations
- 80Captures
Metric Options: Counts1 Year3 YearSelecting the 1-year or 3-year option will change the metrics count to percentiles, illustrating how an article or review compares to other articles or reviews within the selected time period in the same journal. Selecting the 1-year option compares the metrics against other articles/reviews that were also published in the same calendar year. Selecting the 3-year option compares the metrics against other articles/reviews that were also published in the same calendar year plus the two years prior.
Example: if you select the 1-year option for an article published in 2019 and a metric category shows 90%, that means that the article or review is performing better than 90% of the other articles/reviews published in that journal in 2019. If you select the 3-year option for the same article published in 2019 and the metric category shows 90%, that means that the article or review is performing better than 90% of the other articles/reviews published in that journal in 2019, 2018 and 2017.
Citation Benchmarking is provided by Scopus and SciVal and is different from the metrics context provided by PlumX Metrics.
Example: if you select the 1-year option for an article published in 2019 and a metric category shows 90%, that means that the article or review is performing better than 90% of the other articles/reviews published in that journal in 2019. If you select the 3-year option for the same article published in 2019 and the metric category shows 90%, that means that the article or review is performing better than 90% of the other articles/reviews published in that journal in 2019, 2018 and 2017.
Citation Benchmarking is provided by Scopus and SciVal and is different from the metrics context provided by PlumX Metrics.
Metrics Details
- Citations63
- Citation Indexes63
- 63
- CrossRef62
- Captures80
- Readers80
- 80
Review Description
Some mendelian (monogenic) disorders directly conferring increased susceptibility are associated with diverse infectious organisms, whereas others are restricted in scope to specific genera or even to one species. So far, most investigations of primary immunodeficiency disorders have focused on those conferring susceptibility to viral, bacterial, or mycobacterial infections, providing powerful insight into human determinants of host resistance to these microbes. Monogenic disorders that increase susceptibility to fungal infections are increasingly being recognised. Although infections associated with these disorders are probably less common than are iatrogenic associated mycoses, they provide valuable insight into human immunity to fungal infections. Investigation of these immunological pathways will ultimately lead to improvements in management of such infections in secondarily immunocompromised patients.
Bibliographic Details
http://www.sciencedirect.com/science/article/pii/S1473309911702171; http://dx.doi.org/10.1016/s1473-3099(11)70217-1; http://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&scp=80053281484&origin=inward; http://www.ncbi.nlm.nih.gov/pubmed/21958581; http://linkinghub.elsevier.com/retrieve/pii/S1473309911702171; http://api.elsevier.com/content/article/PII:S1473309911702171?httpAccept=text/xml; http://api.elsevier.com/content/article/PII:S1473309911702171?httpAccept=text/plain; https://linkinghub.elsevier.com/retrieve/pii/S1473309911702171; http://dx.doi.org/10.1016/s1473-3099%2811%2970217-1; https://dx.doi.org/10.1016/s1473-3099%2811%2970217-1
Elsevier BV
Provide Feedback
Have ideas for a new metric? Would you like to see something else here?Let us know